BPC-157 Australia — research guide, purity, handling and pricing

BPC-157 is a synthetic 15-amino-acid fragment derived from a sequence identified in human gastric juice. It is short, comparatively stable in aqueous solution, and inexpensive to synthesise — which is why it appears so frequently in preclinical laboratory work.

It is not a registered therapeutic good in Australia. It is supplied here as a laboratory reference material for in-vitro research only, and is not approved by the TGA for human or veterinary use.

The BPC-157 literature is overwhelmingly preclinical: cell-culture and rodent models examining tissue-repair signalling, angiogenesis-related pathways, tendon and ligament fibroblast behaviour, and gastrointestinal mucosal models.

Human clinical evidence is limited and we make no claims about effects in humans. Read the primary sources linked at the bottom of this page and assess the methodology yourself.

We do not publish human dosing protocols and nothing here is a dosing recommendation. What follows is concentration arithmetic for laboratory record-keeping only.

Published animal-model papers express quantities as µg per kg of body mass of the model organism, not as fixed human amounts. Any figure you see quoted online as a 'BPC-157 dose' is not derived from a registered therapeutic label, because no such label exists.

Concentration maths for a 5mg vial: reconstituted with 2mL of bacteriostatic water it yields 2.5mg/mL, so 0.1mL on a 1mL insulin syringe measures 250µg. Reconstituted with 5mL it yields 1mg/mL, so 0.1mL measures 100µg. Choose the volume that puts your working quantity in the easily readable middle of the syringe barrel rather than at the extreme tip.

Record the reconstitution date, volume and lot number in your notes at the moment you reconstitute. Concentration is only traceable if the volume is written down — it cannot be recovered from the vial afterwards.

Wipe the stopper with an alcohol prep swab, then add bacteriostatic water slowly down the inner wall of the vial rather than directly onto the powder cake. Swirl gently until clear; never shake, which shears the peptide chain.

Aliquot into single-use volumes where the protocol allows — repeated freeze-thaw cycles are the most common cause of avoidable peptide degradation.

Label every aliquot with the lot number so every result stays traceable back to the batch Certificate of Analysis.

TB-500 (a synthetic fragment of thymosin beta-4) appears alongside BPC-157 in the tissue-repair research literature, but the two are structurally unrelated and are studied through different mechanistic pathways — TB-500 work centres on actin binding and cell migration, BPC-157 work on angiogenesis-related and gastrointestinal signalling.

Researchers running comparative in-vitro work commonly lot-match both vials to their Certificates of Analysis so any observed difference is attributable to the compound rather than batch variation. Both are stocked in our recovery range.

A 5mg lyophilised vial is A$89 including GST, dispatched cold-chain packed and tracked from our Australian storage and dispatch facility — no import wait, no customs risk, and no membership or minimum order.

Orders placed before 12pm AEST ship same day, and express shipping is free on orders over A$199. Bacteriostatic water, 31G insulin syringes and alcohol prep swabs ship in the same parcel.

Lyophilised (freeze-dried) peptides are shipped cold-chain packed and are typically stored at -20°C for long-term storage, or 2-8°C for short periods before reconstitution.

Once reconstituted with bacteriostatic water, vials are generally refrigerated at 2-8°C and protected from light and repeated freeze-thaw cycles.

Every Aussie Peptides vial carries a lot number that maps to a batch Certificate of Analysis, so purity and identity can be recorded alongside your experimental data.

Materials on this site are supplied strictly for in-vitro laboratory research. They are not therapeutic goods, are not approved by the TGA for human use, and are not supplied for human or veterinary consumption.

Purchasers must be 18 or over and are responsible for handling, storing and disposing of research materials in line with their institution's requirements and applicable Australian law.

Nothing on this page is medical advice, a dosing protocol, or a claim of therapeutic benefit. It summarises what the published research literature investigates.